Our current study provided novel insights into the mechanisms underlying ER+ BC drug resistance and demonstrated that PFKFB4 plays an essential role during tumour cell stemness transformation and acquired CDK4/6 inhibitor resistance. This evidence concerns the gene CDK4 and neoplasm.